Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (GB:0JDI)
LSE:0JDI
RESEARCH TOOLSreports
Holding GB:0JDI?
Track your performance easily
See the Price Targets and Ratings of:
0JDI Analyst Ratings
Moderate Buy
9 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0JDI Stock 12 Month Forecast
Average Price Target
$61.53
▲(50.11% Upside)
| Highest Price Target$82.00 | Average Price Target$61.53 | Lowest Price Target$37.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
Assigned
09/11/24
Leerink Partners
Reiterated
09/10/24
Wells Fargo
Assigned
08/30/24
Bank of America Securities
Reiterated
08/30/24
J.P. Morgan
Reiterated
08/26/24
TD Cowen
Assigned
08/02/24
Oppenheimer
Reiterated
08/02/24
Goldman Sachs
Reiterated
08/02/24
Barclays
Reiterated
08/02/24
Morgan Stanley
Reiterated
08/02/24
BMO Capital
$67→$60
Hold
46.38%
Upside
Downgraded
08/02/24
Ionis Pharmaceuticals: Hold Rating Amid Pipeline Potential and Strategic Challenges
Needham
$60
Buy
46.38%
Upside
Reiterated
08/01/24
Ionis Pharmaceuticals Surpasses Expectations: A Strong Buy Recommendation
RBC Capital
$70
Buy
70.77%
Upside
Assigned
08/01/24
Ionis Pharmaceuticals (IONS) Receives a Buy from RBC Capital
Citi
$60
Buy
46.38%
Upside
Reiterated
07/22/24
Buy Rating on Ionis Pharmaceuticals Backed by Strong Trial Results for Angelman Syndrome Drug
Stifel Nicolaus
$50→$53
Hold
29.30%
Upside
Reiterated
06/27/24
Ionis Pharmaceuticals price target raised to $53 from $50 at StifelIonis Pharmaceuticals price target raised to $53 from $50 at Stifel
Best Analysts Covering Ionis Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy GB:0JDI and Sell After:
1 Month
xxx
Success Rate
10/15 ratings generated profit
Average Return
+2.42%
initiated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.42% per trade.
3 Months
xxx
Success Rate
16/27 ratings generated profit
Average Return
+2.58%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.26% of your transactions generating a profit, with an average return of +2.58% per trade.
1 Year
Success Rate
11/15 ratings generated profit
Average Return
+16.49%
initiated a buy rating 12 months ago
Copying Gary Nachman's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +16.49% per trade.
2 Years
xxx
Success Rate
13/15 ratings generated profit
Average Return
+23.89%
initiated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 86.67% of your transactions generating a profit, with an average return of +23.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0JDI Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
21
19
19
7
6
Buy
11
12
11
14
12
Hold
7
11
13
11
7
Sell
2
2
1
1
1
Strong Sell
0
0
0
0
0
total
41
44
44
33
26
Each month's total comprises the sum of three months' worth of ratings.
0JDI Financial Forecast
0JDI Stock Forecast FAQ
What is GB:0JDI’s average 12-month price target, according to analysts?
Based on analyst ratings, Ionis Pharmaceuticals’s 12-month average price target is $61.53.
What is GB:0JDI’s upside potential, based on the analysts’ average price target?
Ionis Pharmaceuticals has 50.11% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ionis Pharmaceuticals a Buy, Sell or Hold?
Ionis Pharmaceuticals has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 5 hold ratings and 1 sell ratings.
What is Ionis Pharmaceuticals’s share price target?
The average share price target for Ionis Pharmaceuticals is $61.53. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $82.00 ,and the lowest forecast is $37.00. The average share price target represents 50.11% Increase from the current price of $40.99.
The highest analyst share price target is $82.00 ,and the lowest forecast is $37.00. The average share price target represents 50.11% Increase from the current price of $40.99.
What do analysts say about Ionis Pharmaceuticals?
Ionis Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of Ionis Pharmaceuticals?
To buy shares of GB:0JDI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.